Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma

Christian Hoffmann(Hochschule für Angewandte Wissenschaften Kiel), Heinz‐August Horst(Goethe University Frankfurt), Thomas Buhk(Universität Hamburg), Eva Wolf(MUC Research (Germany)), Gerd Fätkenheuer(University of Cologne), Albrecht Stoehr, Hans‐Jürgen Stellbrink, Uwe Siebert(Harvard University), Hans Jaeger(Joint United Nations Programme on HIV/AIDS), Andreas Plettenberg(Institute for Interdisciplinary Medicine)
AIDS
June 30, 2003
10.1097/00002030-200307040-00013
Cited by 123

Related Papers

Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia
|Blood|2005|537
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
|Blood|2018|421
Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)
|PLoS Medicine|2013|362